Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert S. who wrote (8362)	1/18/1999 6:31:00 PM
From: aknahow	Read Replies (2) \| Respond to of 17367

Robert_S. Until I was aware of what was required to end the trial I was convinced that more accruals were needed because the placebo group was doing much better than expected making a larger sized trial necessary to demonstrate efficacy. If Neuprex was not working I accepted the concept that the trial would simply not have been continued. So, yes if the information available to me changes I change my opinion. BTW your link was not to one of my post but I confess to changing my mind about most things, whenever I have new information or whenever I feel like it. My reply which I guess you were referencing was this: XOMA. Bull or Bear? To: Edward Paule From: george wohanka Sep 3 1998 7:02PM EST Reply #7162 of 8363 Nice logic. I like your concept better than mine which is/was they just feel they must check the data at least every 6 months. So gee, first I tell someone else I like there logic better than mine, then I get new information and change my mind and you want to try to make some point! I do change my mind about many things but not all things, Robert_S.